Back to EYPT

EyePoint Pharmaceuticals, Inc. 8-K

Accession 0001193125-18-287394

Filing information

CIK
0001314102
Report date
2018-09-12
Filing date
2018-09-28
Form
8-K
Primary document
d454251d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.